Brief: U3O8 Announces Proposed Reverse Takeover Transaction With Diagnostic Lab Corporation

Green Shift Commodities.

03/03/2020 20:07

March 3 (Reuters) - U3O8 Corp  UWEh.V :
    * U3O8 CORP. ANNOUNCES PROPOSED REVERSE TAKEOVER TRANSACTION
WITH
DIAGNOSTIC LAB CORPORATION, INC.
    * U3O8 CORP - PROPOSED TRANSACTION IS ANTICIPATED TO BE
COMPLETED
BY WAY OF SHARE EXCHANGE
    * U3O8 CORP - DIAGNOSTIC LAB CORPORATION, INC. IS SEEKING A
LISTING IN CANADA THROUGH A RTO TRANSACTION WITH U3O8 CORP
    * U3O8 CORP - DLC WILL ADVANCE U3O8 AN INTEREST-FREE BRIDGE
LOAN
THAT WILL BE USED PRIMARILY TO PAY EXPENSES RELATING TO PROPOSED
TRANSACTION
    * U3O8 CORP - IN ADDITION, DLC SHALL UNDERTAKE A SERIES OF
FINANCINGS TO FUND BUSINESS ON TERMS TO BE ANNOUNCED
    * U3O8 CORP - DLC WILL BECOME A WHOLLY OWNED SUBSIDIARY OF
U3O8
CORP
    * U3O8 - UPON COMPLETION, ANTICIPATED THAT ALL DIRECTORS,
OFFICERS
OF CO OTHER THAN 1 NOMINEE DIRECTOR WILL RESIGN & BE REPLACED BY
NOMINEES OF DLC
    * U3O8 CORP - ANTICIPATED THAT PROPOSED TRANSACTION WILL NOT
BE A
"NON-ARM'S LENGTH TRANSACTION"
    * U3O8 - A NUMBER OF RESULTING ISSUER SHARES REPRESENTING
85% OF
TOTAL RESULTING ISSUER SHARES WILL BE ISSUED TO DLC SHAREHOLDERS

Source text for Eikon:  ID:nGNX515n9j 
Further company coverage:  UWEh.V 

 ((Reuters.Briefs@thomsonreuters.com;;))